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There are numerous genes for which loss-of-function mutations do not produce apparent phenotypes even
though statistically signiﬁcant quantitative changes to biological pathways are observed. To evaluate the
biological meaning of small effects is challenging. Bardet–Biedl syndrome (BBS) is a heterogeneous autosomal
recessive disorder characterized by obesity, retinopathy, polydactyly, renal malformations, learning disabilities
and hypogenitalism, as well as secondary phenotypes including diabetes and hypertension. BBS knockout mice
recapitulate most human phenotypes including obesity, retinal degeneration and male infertility. However, BBS
knockout mice do not develop polydacyly. Here we showed that the loss of BBS genes in mice result in accu-
mulation of Smoothened and Patched 1 in cilia and have a decreased Shh response. Knockout of Bbs7 com-
bined with a hypomorphic Ift88 allele (orpk as a model for Shh dysfuction) results in embryonic lethality with
e12.5 embryos having exencephaly, pericardial edema, cleft palate and abnormal limb development, phenotypes
not observed in Bbs7
2/2 mice. Our results indicate that BBS genes modulate Shh pathway activity and interact
genetically with the intraﬂagellar transport (IFT) pathway to play a role in mammalian development. This study
illustrates an effective approach to appreciate the biological signiﬁcance of a small effect.
INTRODUCTION
The use of loss-of-function mutations is an informative
approach to identify the functions of a given gene. Some
loss-of-function mutations generate dramatic phenotypes in
model systems, and these mutations have been pivotal to
understanding biological pathways and molecular mechanisms
for human diseases. However, numerous genes do not produce
apparent phenotypes when knocked out, even though statistic-
ally signiﬁcant quantitative changes to biological pathways are
observed. To evaluate the biological meaning of these small
effects is a scientiﬁc challenge.
Cilia are microtubule-based structures that extend from the
cell surface of most cells and are classiﬁed as either motile or
primary cilia (immotile). The importance of cilia is high-
lighted by defects in cilia that lead to the development of a
wide range of human diseases termed ciliopathies, which
include primary ciliary dyskinesis, polycystic kidney disease,
nephronophthisis, Joubert syndome, Senior–Loken syndrome,
Meckel–Gruber syndrome, oro-facial-digital syndrome,
Alstrom syndrome and Bardet–Biedl syndrome (BBS).
BBS (OMIM 209900) is an autosomal recessive genetic
disorder characterized by obesity, retinopathy, polydactyly,
renal malformations, learning disabilities and hypogenitalism,
as well as diabetes and hypertension. To date, 16 BBS genes
have been shown to independently cause the disorder
(1–13). Seven BBS proteins (BBS1, BBS2, BBS4, BBS5,
BBS7, BBS8 and BBS9) along with an interacting protein
known as BBIP10 form a complex called the BBSome,
which is involved in ciliary membrane biogenesis (14).
Although several ciliary membrane proteins have been
shown to require the BBSome for transport to cilia (15,16),
the physiological relevance of some of these ciliary membrane
proteins to BBS phenotypes are currently unknown.
BBS knockout mice display most human BBS phenotypes
including obesity, retinal degeneration and male infertility.
However, unlike human BBS patients, BBS knockout mice
do not develop polydactyly (17–20). Most polydactyly pheno-
types typically have the sonic hedgehog (Shh) pathway defects
and the Shh pathway is known to control tissue patterning
during mammalian development. Shh activates the pathway
by binding to its receptor Patched 1 (Ptch1) releasing
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the signal via Gli transcription factors. There are three Gli pro-
teins (Gli1, Gli2 and Gli3) in vertebrates. Gli2 and Gi3 are the
primary regulators of the pathway during development (21).
It is well established that cilia are required for hedgehog
pathway signaling (22–27). BBS mutant mice have motile
cilia defects in brain ependymal cells, trachea epithelial cells
and sperm ﬂagella, but they do not have apparent primary
cilia morphological defects, although the primary cilium
may have functional deﬁcits (17–20). While the loss of BBS
function has been shown to result in wingless-type MMTV in-
tegration site (Wnt)/planar cell polarity defects (28–31), it is
not clear whether the loss of BBS genes also affect the Shh
pathway. The lack of the polydactyly phenotype in BBS
mutant mice prompted us to investigate the underlying mo-
lecular defects in BBS mutant mice. Here we showed that
Smo and Ptch1 are endogenous cargos of the BBSome and
that the loss of BBS genes in mice results in accumulation
of Smo and Ptch1 in cilia and lead to a quantitative decrease
in Shh response. To evaluate the biological signiﬁcance of
this quantitative decrease in Shh signaling, we investigated
whether knockout of BBS function could modify another
cilia-related mutation, a hypomorphic allele of Ift88 known
as orpk (oak ridge polycystic kidney). We show that homozy-
gous knockout of Bbs7 combined with the homozygous Ift88
orpk allele results in embryonic lethality. The e12.5 embryos
have exencephaly, pericardial edema, cleft palate and polydac-
tyly. Our results indicate that BBS genes modulate Shh
pathway activity and interact genetically with the intraﬂagellar
transport (IFT) pathway to inﬂuence mammalian development.
RESULTS
The BBSome regulates Smo ciliary localization
and Shh signaling
One of the cardinal features of BBS is post-axial polydactyly,
which is present in most human BBS patients. However, none
of the BBS mutant mice (Bbs1
M390R/M390R knockin, Bbs2
2/2,
Bbs4
2/2, Bbs6
2/2 and Bbs7
2/2) develop polydactyly (17–
20). Most mutant mice that have polydactyly have defective
Shh signaling; therefore, we examined the Shh pathway in
BBS mutant mice. We isolated mouse embryonic ﬁbroblast
(MEF) cells and embryonic brain cells from wild-type (WT)
and Bbs mutant mice (Bbs1
M390R/M390R knockin, Bbs2
2/2,
Bbs4
2/2 and Bbs7
2/2). MEF and embryonic brain cells are
known to respond to hedgehog ligand stimulation (32). Smo,
one of the hedgehog pathway components, localizes to cilia
when stimulated by Shh ligand or by pathway agonists such
as N-Methyl-N′-(3-pyridinylbenzyl)-N′-(3-chlorobenzo[b]
thiophene-2-carbonyl)-1,4-diaminocyclohexane (SAG). To
determine whether the loss of the BBSome affects Smo
ciliary localization, we stimulated cultured WT and Bbs7
2/2
MEF cells with the Shh pathway agonist SAG. About 45%
of cilia are Smo positive in BBS mutant MEF cells even
without stimulation with SAG (Fig. 1A and C) compared
Figure 1. The BBSome regulates Smo ciliary localization and Shh signaling. (A) Cultured MEF cells from WT and Bbs7
2/2 mice stimulated with dimethyl
sulfoxide (DMSO) or with Shh pathway activator N-Methyl-N′-(3-pyridinylbenzyl)-N′-(3-chlorobenzo[b]thiophene-2-carbonyl)-1,4-diaminocyclohexane
(SAG) were stained with anti-acetylated tubulin (green) as a cilia marker and anti-Smo (red). (B) Quantitation of percentage of cells with cilia with or
without SAG treatment found no differences between WT and Bbs7
2/2 MEF cells. (C) Quantitation of percentage of cilia with Smo staining when treated
with DMSO or SAG. (D) qPCR for Gli1 and Patched 1 from cultured Bbs7
2/2 MEF cells stimulated with SAG showed a 20–30% decreased Shh pathway
output compared with WT MEF cells when normalized to actin. Scale bar represents 10 mm. ∗P , 0.02.
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stimulation increases the percentage of cilia that are Smo posi-
tive to nearly 100% in both WT and Bbs7
2/2 cells (Fig. 1A
and C). Similar results were obtained with cultured brain
cells (data not shown). These data indicate that the loss of
BBS increases the basal level of Smo in cilia, perhaps by
affecting Smo retrograde transport out of cilia, since BBS
genes have been shown to be required for retrograde transport
in model systems including zebraﬁsh and Chlamydomonas
reinhardtii (33,34). Similar results are obtained using MEF
cells from Bbs1
M390R/M390R knockin, Bbs2
2/2 and Bbs4
2/2
(data not shown). To determine whether the increased ciliary
localization of Smo activates the Shh pathway, we examined
the expression of Gli1 and Ptch1, two genes whose expres-
sions are upregulated when the Shh pathway is activated. To
our surprise, the increased ciliary localization of Smo in the
absence of normal BBS genes results in a 20–30% decrease
in Shh pathway activation in MEF cells (Fig. 1D). These
results are consistent with the notion that ciliary localized
Smo has two states: inactive and active. Ciliary localization
of Smo is not sufﬁcient to activate the pathway (25). The
BBSome may modulate the conversion of Smo from the
inactive to the active state within cilia.
The BBSome interacts with Smo
To further analyze how the loss of the BBSome affects ciliary
localization of Smo, we examined whether the BBSome
interacts physically with Smo. This was performed by
co-transfection of each individually hemagglutinin (HA)-tagged
BBSome component (BBS1, 2, 4, 5, 7, 8 and 9) with either GFP-
or Flag-tagged Smo. Using a reciprocal immunoprecipitation
assay, we demonstrated that full-length Smo interacts with
several BBSome subunits with BBS1 showing the strongest
interaction (Fig. 2A and Supplementary Material, Fig. S1D).
BBS1 speciﬁcally binds to the C-terminal cytoplasmic tail of
Smo (amino acids 477–793) (Fig. 2B). It has been previously
demonstrated that the minimal region of Smo that is required
for activity comprises amino acids 1–637 (35). We demon-
strated with deletion analysis that BBS1 binds to the
C-terminal cytoplasmic tail of Smo between amino acids
552–637 (Fig. 2C), overlapping the critical domain for Smo ac-
tivity. Constitutively active or inactive mutations of Smo do not
affect ciliary localization of Smo, nor do they affect interaction
with BBS1 (Supplementary Material, Fig. S1).
Studies from Drosophila show that hedgehog induces
phosphorylation of multiple Ser/Thr residues to antagonize
multiple Arg clusters in the Smo C-terminal cytoplasmic tail
to induce an Smo conformation change and activate the
pathway (36). Vertebrate Smo also contains two clusters of
basic amino acids in the cytoplasmic tail (Fig. 2E), and Shh
induces a conformational change (36). We asked whether
this conformational switch regulates the interaction with the
BBSome. Deletion of a stretch of 10 basic amino acids in
the Smo C-terminal tail enhanced its interaction with BBS1
(Fig. 2D), whereas deleting a stretch of 17 basic amino acids
has minimal effect on the interaction with BBS1. None of
these deletion mutations affects the ciliary localization of
Smo (Supplementary Material, Fig. S1).
The BBSome regulates Ptch1 ciliary localization
Ptch1, another membrane protein of the hedgehog pathway, is
a hedgehog receptor and localizes to the cilia. To determine
Figure 2. The BBSome interacts with the C-terminus of Smo. Shown are reciprocal immunoprecipitation assays in 293T cells of hemagglutinin (HA)-tagged
BBS1 with GFP-tagged Smo (A) and HA-tagged Ccdc28 as a negative control (B). HA-BBS1 interacts with the Flag-tagged Smo C-terminal tail, which contains
two stretches of basic amino acids. BBS1 interacts with the Smo C-terminal region that contains a stretch of 17 amino acids rich in basic residues, but not with an
Smo C-terminal region that contain a stretch of only 10 basic amino acids. (C) Domain-binding analysis reveals that BBS1 binds to the Smo C-terminal region
between amino acid 552–637. (D and E) A stretch of 10 basic amino acids in the Smo C-terminal tail regulates the interaction between Smo and BBS1.
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we stained MEF cells from WT and Bbs7
2/2 mice with anti-
body against Ptch1. Increased Ptch1 staining was detected in
the cilia of Bbs7
2/2 MEF cells compared with WT MEF
cells when stimulated with SAG (Fig. 3A and B). Similar
results are obtained using MEF cells from Bbs1
M390R/M390R
knockin, Bbs2
2/2 and Bbs4
2/2 (data not shown). This result
may explain the deceased Shh response in BBS knockout
cells as Ptch1 is a negative regulator of the Shh pathway.
To further analyze how the loss of BBSome affects Ptch1
ciliary localization, we tested whether the BBSome directly
interacts with Ptch1. Co-transfection of Flag-tagged
C-terminal cytoplasmic tail of Ptch1 along with HA-tagged in-
dividual BBSome subunits (BBS1, 2, 4, 5, 7, 8 and 9) revealed
that the C-terminal tail of Ptch1 interacts strongly with BBS1
(Fig. 3C), while no interaction or very weak interaction was
detected with other BBSome subunits. Structure analysis using
SMART does not reveal any domains analogous to any
known proteins in the C-terminal tail of Ptch1 and only four
low-complexity regions are found. We therefore chose to
make deletions that separate these four low-complexity
regions and showed that amino acids 1322–1447 of the
C-terminus of Ptch1 are required for binding to BBS1 (Fig. 3D).
Genetic interaction between Bbs7 and Ift88 affects
mammalian development
Although BBS knockout mice do not develop polydactyly, our
in vitro studies indicate statistically signiﬁcant differences in
the Shh pathway activation in response to Shh agonist, sug-
gesting that the loss of BBS proteins may sensitize mice to
hedgehog pathway defects. We reasoned that further reduction
in the Shh response in BBS mutant mice would result in
polydactyly. Ift88 hypomorphic ORPK mice have greatly
decreased Ift88 protein levels, improper IFT complex B for-
mation, hedgehog signaling defects and polydactyly (Supple-
mentary Material, Fig. S5). Interestingly, ORPK MEF cells
also accumulate Smo in the cilium even without SAG stimu-
lation (Supplementary Material, Fig. S5C), consistent with
the ﬁnding that polycystin-2 is accumulated inside the
cilium in ORPK mice (37). The BBSome interacts with IFT
proteins when expressed in cells and co-localizes at punctae
inside the cilium (Supplementary Material, Fig. S6), although
the endogenous protein interaction cannot be detected (Sup-
plementary Material, Fig. S5B). In ORPK mice, polydactyly
is only displayed in the hindlimb (38). Although ORPK
mice have multiple organ defects including cystic kidneys,
hydrocephalus, liver ﬁbrosis, pancreatitis and retinal degener-
ation (39–41), they survive to adulthood on a C57BL/6 back-
ground and otherwise appear to be normal. It has been shown
that knocking down any BBSome subunit in cell culture
resulted in the loss of BBSome formation (42). We have con-
ﬁrmed that there is no BBSome formation in the absence of
Bbs7 (data not shown). Therefore, we use Bbs7
2/2 as a surro-
gate for the loss of the BBSome. When we crossed Bbs7+/2;
orpk+/2 double heterozygotes with each other. No double
mutant offspring were found at weaning out of 145 offspring,
suggesting that they may die prenatally or perinatally. We
therefore closely followed the mice at birth and genotyped
99 P0 offspring. No double mutants were found, indicating
prenatal death. Timed matings were set up and fetuses were
collected at e11.5–13.5. Five of 74 (6.7%) fetuses were
Figure 3. The BBSome regulates Ptch1 ciliary localization. (A) Cultured MEF cells from WT and Bbs7
2/2 mice stimulated with the Shh pathway activator,
SAG, were stained with anti-acetylated tubulin (green) as a cilia marker and anti-Ptch1 (red). (B) Quantitation of the intensity of Ptch1 staining inside cilia when
treated with SAG. Bbs7
2/2 MEF cells have statistically higher amount of Ptch1 inside the cilia compared with WT MEF cells. (C) Shown are reciprocal immu-
noprecipitation assays in 293T cells of HA-tagged each BBSome components with Flag-tagged Ptch1. Ptch1 interacts with the BBSome through the BBS1
subunit. (D) BBS1 interacts with the C-terminal tail of Ptch1 between amino acid 1322–1447. Scale bar represents 10 mm.
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two independent loci). Double-mutant embryos have exence-
phaly, pericardial edema, no eye development and cleft
palate (Fig. 4). Neither the homozygous single mutants, nor
homozygous single mutant animals that were heterozygous
at the other locus had phenotypes similar to the double homo-
zygous mutant mice. Limb development of the double mutant
embryos is delayed in that e11.5 limbs morphologically look
like e10.5 WT limbs and e12.5 limbs morphologically look
like e11.5 WT limbs and lack calciﬁcation. In addition to
the delayed morphological appearance, the e12.5 limb buds
of the double-mutant embryos are broad compared with
e11.5 WT limb buds, suggesting polydactyly (Fig. 4D).
Double mutants do not survive beyond e12.5, which precluded
us from identifying the exact digit numbers. These ﬁndings in-
dicate that double mutants have severe Shh pathway defects
and resemble complete knockout of IFT genes. Indeed, MEF
cells from double mutants have further decreased Shh re-
sponse when treated with SAG compared with Ift88(orpk)
single mutant cells as demonstrated by quantitative polymer-
ase chain reaction (PCR) of Gli1, a direct target of Shh
pathway activation (Fig. 4E and F). The neural tubes, other
than the brain region, are closed and no apparent Wnt/PCP
(planar cell polarity) defects are found in the double-mutant
embryos. Together, these results indicate that BBS and IFT
genes interact genetically during mammalian development.
DISCUSSION
The importance of cilia is highlighted by the fact that numer-
ous diseases have been associated with defects in cilia struc-
ture or cilia function. It is well established that cilia are
required for the hedgehog pathway (23–26,43,44). Involve-
ment of cilia in Wnt/b-catenin and Wnt/PCP signaling path-
ways are more controversial (45–47), although accumulating
evidence supports that cilia are also important for these path-
ways (30,48–51). It has been reported that BBS knockout
mice develop phenotypes similar to Wnt/PCP pathway
mutants including midbrain exencephaly and open eyelids
(30). However, we have not detected such defects in any of
the BBS mutant mice (Bbs1
M390R/M390R knockin, Bbs2
2/2,
Bbs4
2/2, Bbs6
2/2 and Bbs7
2/2) either on 129Sv, C57BL6
or mixed genetic backgrounds (our unpublished data). We
also recover mendelian ratios of embryos at e12.5. One
possible explanation for the discrepancy between our mice
and other reported mouse models is that BBS mutant mice
generated in our laboratory were generated using homologous
recombination, while BBS mutant mice that showed PCP
defects were generated by gene-trapping methodology.
The accumulation of endogenous Smo in cilia implies that
transport of Smo out of cilia is dependent on BBSome func-
tion. This result is reminiscent of the localization of Smo in
Dync2h1 mutant MEFs (46,52). In Dync2h1 mutant MEFs,
Figure 4. Genetic interaction between Bbs7 and Ift88 regulates mammalian development. Bbs7 and Ift88orpk double mutant at e12.5 showed gross morphologic-
al defects (A), exencephaly, pericardial edema and lack of eyes (B), cleft palate (C) and limb developmental delay and polydactyly (D). MEF cells from Bbs7 and
Ift88orpk double mutant have further decreased the Shh response by RT–PCR assay of Gli1 expression level compared with Ift88orpk single mutant when
treated with SAG (E), we diluted WT cDNA by 10-fold in order to see Gli1 band in double mutant.
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is not sufﬁcient to activate the hedgehog pathway. While
stimulation of Dync2h1 MEF cells with SAG does not increase
Smo ciliary localization, stimulation of BBS mutant MEF cells
with SAG further increases Smo ciliary localization, indicat-
ing that BBS mutant MEF cells can respond to Shh pathway
activation, although the response is diminished. This differ-
ence could explain why Dync2h1 mutant mice have develop-
mental defects including polydactyly, while BBS mutant mice
do not. Consistent with the results from mouse studies, skin
ﬁbroblast cells derived from the most common human BBS
mutation: BBS1M390R also accumulate Smo in the cilia
even without SAG stimulation (Supplementary Material,
Fig. S8), indicating that the underlying mechanism is con-
served between mouse and humans.
The accumulation of both Smo and Ptch1 in BBS null MEF
cells is consistent with genetic studies in zebraﬁsh in which
knockdown of BBS gene expression results in the delay of
melanosome retrograde transport (34), which is mediated by
the dynein complex. In an attempt to identify potential
binding partners for BBS proteins, we performed yeast
2-hybrid screens using BBS proteins as baits. Interestingly,
cytoplasmic dynein light intermediate chain 1 and p150
Glued
dynactin interact with BBS proteins. These interactions were
conﬁrmed in vivo using co-immunoprecipitation assays (Sup-
plementary Material, Fig. S3). Considering that the BBSome
has been suggested as a cargo for the IFT complex, and report-
edly serves as a bridge between IFT complex A and IFT
complex B in C. elegans (33,53), it was somewhat surprising
to us that no IFT proteins were identiﬁed in our Y2H screen.
One explanation is that the interaction requires the intact
BBSome and the intact IFT complex, not individual compo-
nents. The cargo—BBSome—dynein complex link could be
an underlying molecular mechanism involved in BBS pheno-
types. How the loss of BBS affects the cargo–dynein
complex interaction will be the focus of future work.
Several possibilities can explain why increased ciliary local-
ization of Smo did not result in increased Shh pathway activa-
tion. First, Smo localized within cilia has two states:
inactivated and activated (25). The BBSome may be required
to modulate the conversion from the inactive to the active state
inside the cilium. Secondly, Ptch1, a negative regulator of the
hedgehog pathway, normally moves out of cilia when the
pathway is activated. However, accumulation of Ptch1
within cilia in the absence of BBS components may inhibit
Shh pathway activation. Recent studies have shown that Shh
ligand transmits the signal through regulating Gli-Su(fu)
ciliary entry and subsequent dissociation of Gli and Su(fu)
leading to the activation of Gli transcription factors and acti-
vation of the pathway (54–56). Although the BBSome can
interact with Gli1, Gli2 and Su(fu) (Supplementary Material,
Fig. S4), unlike Dync2h1 MEF cells, BBS mutant MEF cells
do not accumulate Gli2 inside cilia (Supplementary Material,
Fig. S7), suggesting that the BBSome may transport speciﬁc
ciliary membrane proteins.
In Drosophila, the atypical kinesin Costal-2 serves as an
adaptor between transmembrane transducer Smo and the tran-
scriptional effector Cubitus interruptus (57). The mammalian
homolog of Costal-2 is kif7. Whether kif7 has a similar role
as Costal-2 to bridge Smo to Gli proteins is currently
unknown. Physical interactions between the BBSome, Smo
C-terminus and Gli-Su(fu) suggests that the BBSome may
play a role in this process. Attempts to detect the physical
interactions among the endogenous BBSome, Smo and
Gli-Su(fu) were unsuccessful. This is not surprising, consider-
ing that the BBSome is a part of a transport system, and we
thus expect that the interactions between the BBSome and
its cargoes [Smo, Ptch1 and Gli-Su(fu) or other hedgehog
pathway components] will be transient and weak due to the
need to constantly load and release cargoes. One illustrative
example is that IFT complexes are known to require both
the antegrade motor, kinesin II and the retrograde motor,
dynein, to power the movement of IFT particles. No endogen-
ous interactions between IFT complexes and motors have been
detected. Another example is that the BBSome and IFT com-
plexes co-localize inside Chlamydomonoas ﬂagella and the
BBSome appears to be transported by IFT particles (33), yet
the puriﬁed BBSome does not contain IFT components.
Another factor that may limit our detection of endogenous
protein interactions is that the BBSome may only interact
with hedgehog pathway components inside cilia, and only a
portion of these proteins (both the BBSome and hedgehog
pathway components) actually localize to cilia. Elevation of
protein concentrations inside cells by overexpressing them
will increase the chance to detect this type of interaction.
That Smo co-localizes with BBSome particles inside the
cilium (Supplementary Material, Fig. S2) indicates that they
may interact in vivo.
The phenotypes of Bbs7 and Ift88orpk double mutants
resemble those of complete knockout of IFT genes, indicating
that they lose responsiveness to Shh ligand. Even though
single homozygous mutants of either gene have diminished
Shh responsiveness, single mutant mice survive to adulthood,
in stark contrast to the double mutants. Creation of double
mutants is an effective approach to evaluate the biological
meaning of small effects like we observe for Shh pathway
activation when BBS genes are deleted. The delayed develop-
ment of the limb in the double-mutant embryos, together with
the fact that the double mutants do not survive beyond e12.5,
precludes the determination of the exact nature of digit devel-
opment in the double mutants. To further support that double
mutants might develop polydactyly, MEF cells from double
mutants fail to form cilia (manuscript in preparation), unlike
in any single mutants. Future deletion of BBS genes in the
limb using Prx1-cre, which is expressed in the limb mesenchy-
mal cells, along with crosses to Ift88orpk mice, will provide a
deﬁnitive answer to this question.
MATERIALS AND METHODS
Antibodies and reagents
The hypomorphic Ift88 mouse, Oak Ridge Polycystic Kidney
(orpk mouse), was kindly provided by Dr Gregory Pazour
(University of Massachusetts Medical School, Worcester).
SAG was purchased from Calbiochem (Gibbstown, NJ,
USA). Rabbit anti-Smo antibody was from Abcam (Cam-
bridge, MA, USA), anti-acetylated tubulin was purchased
from Sigma (St. Louis, MO, USA), rabbit anti-Su(fu) and
goat anti-IFT57 antibodies were purchased from Santa Cruz
1950 Human Molecular Genetics, 2012, Vol. 21, No. 9Biotechnology (Santa Cruz, CA, USA). Rabbit anti-IFT57,
IFT88, IFT20 and IFT81 were purchased from Proteintech
(Chicago, IL, USA). Anti-Gli2 antibody is a gift from
Dr Jonathan T. Eggenschwiler (Princeton University, Prince-
ton, NJ, USA), anti-Patched 1 antibody is a gift from Dr
Rajat Rohatgi (Stanford University, Stanford, CA, USA).
Alexa 488-conjugated and Alexa 568-conjugated secondary
antibodies were purchased from Invitrogen (Carlsbad, CA,
USA).
Generation of MEF cells
WT and mutant (Bbs7
2/2, Bbs2
2/2, Bbs4
2/2 and Bbs1
M390R/
M390R knockin) primary MEFs were generated from embryonic
day 12.5 embryos and cultured in Dulbecco’s modiﬁed Eagle
medium with 10% fetal bovine serum and penicillin/strepto-
mycin. To induce cilia formation, MEF cells were grown to
80–90% conﬂuency and serum starved for 24 h; cells were
treated with dimethyl sulfoxide (DMSO) or 100 nM SAG for
16–20 h.
Immunoprecipitation
Differentially tagged human BBS genes (BBS1, BBS2, BBS4,
BBS5, BBS7, BBS8 and BBS9) were co-transfected into 293T
cells. Forty-eight hours after transfection, the cells were lysed
in lysis buffer (1× phosphate buffered saline (PBS), 1%
Triton X-100 and protease inhibitor—Roche, Indianapolis,
IN, USA) and spun at 14 000 rpm for 15 min at 48C. The
supernatants were cleared by incubation with protein G
beads (Pierce, Rockford, IL, USA). Cleared lysates were incu-
bated with antibodies against corresponding tags for 4 h.
Protein G beads were then added and incubated for another
4 h. The beads were washed four times with lysis buffer and
the interactions were detected by western blotting.
Immunoﬂuorescence microscopy
Cells were ﬁxed in 4% paraformaldyhyde in PBS and permea-
bilized with 0.2% Triton X-100 in room temperature for
7 min. Cells were washed 3× PBS and blocked with blocking
buffer (1% bovine serum albumin in PBS). Primary antibodies
were diluted in blocking buffer and incubated at room tem-
perature for 1 h. Cells were washed 3× PBS, blocked with
blocking buffer, then incubated with Alexa 488- or Alexa
568-labeled secondary antibodies (Invitrogen) for 45 min at
room temperature. Nuclei were stained with DAPI (Sigma).
The intensity of staining inside the cilia was measured using
ImageJ.
Quantitative RT–PCR
RNA was isolated from DMSO- or SAG-treated MEF cells
using TRIzol reagent (Invitrogen). cDNA was prepared from
1 mg of total RNA using SuperScript III reverse transcriptase
(Invitrogen). Quantitative PCR was performed with SYBR
Green Supermix (Bio-Rad) and Mx3000P qPCR System (Stra-
tagene) with primers against mouse Gli1 and Patched 1.
Mouse actin was used as an internal control. Primer sequences
are available upon request.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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